Triple-negative and HER2-enriched intrinsic tumours are more aggressive than luminal A and luminal B tumours and are associated with reported 2.5 and threefold risks of mortality [3, 7, 21, 30, 31]. This evidence concerns the gene ERBB2 and neoplasm.